Bristol Myers Squibb Director Acquires Deferred Share Units via Compensation Plan
BRISTOL MYERS SQUIBB CO
Subscribe to track BMY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
### Insider Transaction: Bristol Myers Squibb Co ($BMY)
**Insider:** Phyllis R. Yale (Director)
**Type:** Acquisition (Deferred Compensation)
**Security:** Deferred Share Units
**Shares:** 560.897 @ $62.40
**Total Value:** ~$35,000.00
**Post-Transaction Holdings:** 45,980.077 units
**Date:** 2026-09-30
Comprehensive Analysis
Executive Summary
On October 2, 2026, Bristol Myers Squibb Co ($BMY) director Phyllis R. Yale reported an acquisition of 560.897 Deferred Share Units on September 30, 2026. The units were acquired at a price of $62.40 per unit, representing a total value of approximately $35,000. Following the transaction, Yale holds 45,980.077 Deferred Share Units.
Transaction Breakdown
- Security: Deferred Share Units
- Transaction Code:
A(Acquisition via grant, award, or plan allocation) - Shares/Units: 560.897
- Price per Unit: $62.40
- Value: $34,999.97
- Ownership Nature: Direct
- Footnote Context: The acquisition represents deferred compensation and dividend reinvestments under the 1987 Deferred Compensation Plan for Non-Employee Directors. Each unit converts into one share of common stock upon settlement following cessation of directorship or a predetermined date.
Market Significance
This transaction carries Low trading significance as it constitutes a routine, non-discretionary allocation of director fees and reinvested dividends rather than an open-market purchase or discretionary change in equity exposure.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.